نتایج جستجو برای: thromboembolic disorders

تعداد نتایج: 678710  

Journal: :JAMA 2009
Barbara A Slade Laura Leidel Claudia Vellozzi Emily Jane Woo Wei Hua Andrea Sutherland Hector S Izurieta Robert Ball Nancy Miller M Miles Braun Lauri E Markowitz John Iskander

CONTEXT In June 2006, the Food and Drug Administration licensed the quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccine (qHPV) in the United States for use in females aged 9 to 26 years; the Advisory Committee on Immunization Practices then recommended qHPV for routine vaccination of girls aged 11 to 12 years. OBJECTIVE To summarize reports to the Vaccine Adverse E...

Journal: :The New England journal of medicine 2011
Gregory Piazza Samuel Z Goldhaber

Copyright © 2011 Massachusetts Medical Society. Chronic thromboembolic pulmonary hypertension is defined as mean pulmonary-artery pressure greater than 25 mm Hg that persists 6 months after pulmonary embolism is diagnosed. The 2008 World Symposium on Pulmonary Hypertension1 emphasized the importance of chronic thromboembolic pulmonary hypertension, which occurs in 2 to 4% of patients after acut...

Journal: :Stroke 1998
P Lüdemann D G Nabavi R Junker E Wolff K Papke H Buchner G Assmann E B Ringelstein

BACKGROUND AND PURPOSE Different coagulation disorders have been associated with cerebral venous thrombosis (CVT). Until now, fewer than 50 patients have been reported with CVT and the factor V Leiden (FVL) mutation. Although the prevalence of FVL-positive patients with CVT ranged from 10% to 25%, it was as low as 0.5% to 3% in the control groups. Most other studies had not systematically searc...

2014
Bodil Ivarsson Björn Ekmehag Roger Hesselstrand Göran Rådegran Trygve Sjöberg

Patients with a life-limiting diagnosis of pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) need disease-specific information, ability to cope, and functioning social networks. This cohort study investigated the experiences of PAH and CTEPH patients who received information about their diagnosis, treatment, and management, in addition to coping and ...

2010
Yajun Ren Kirti Patel Terry Crane

Platelets are anuclear cell fragments derived from megakaryocytes that function in the clotting system and circulate in blood for a life span of 6–9 days. Platelets play a major role in the thromboembolic diseases, upon vascular injury, especially arterial vascular injury; platelets rapidly adhere to the exposed subendothelial area, where they become activated by contacting with stimulants like...

Journal: :Serbian Journal of Experimental and Clinical Research 2022

Abstract Leading cause of death in pregnant women still remains venous thromboembolism, with an incidence 1.4 to 4.9 per 100,000 pregnancies. A special group inherited and acquired coagulation disorders associated a susceptibility thrombosis is thrombophilia. Physiological changes during the pregnancy also contribute occurrence thromboembolic diseases (VTE) pregnancy. Total rate thromboembolism...

Journal: :Stroke 1994
R Benfante K Yano L J Hwang J D Curb A Kagan W Ross

BACKGROUND AND PURPOSE The relation between total serum cholesterol level and thromboembolic or nonhemorrhagic stroke is controversial. The Honolulu Heart Program cohort of Japanese-American men provides data which show that elevated serum cholesterol is an independent predictor of thromboembolic stroke as well as coronary heart disease (CHD). The data are presented to suggest that the associat...

Journal: :Lancet 2002
M Baum A U Budzar J Cuzick J Forbes J H Houghton J G M Klijn T Sahmoud

BACKGROUND In the adjuvant setting, tamoxifen is the established treatment for postmenopausal women with hormone-sensitive breast cancer. However, it is associated with several side-effects including endometrial cancer and thromboembolic disorders. We aimed to compare the safety and efficacy outcomes of tamoxifen with those of anastrozole alone and the combination of anastrozole plus tamoxifen ...

Journal: :Haematologica 2010
Frederikus A Klok Klaas W van Kralingen Arie P J van Dijk Fenna H Heyning Hubert W Vliegen Menno V Huisman

BACKGROUND Chronic thromboembolic pulmonary hypertension after pulmonary embolism is associated with high morbidity and mortality. Understanding the incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism is important for evaluating the need for screening but is also a subject of debate because of different inclusion criteria among previous studies. We determined the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید